Verséa Biologics

Verséa Biologics Division is using the latest cutting-edge scientific advancements in regenerative medicine to provide novel treatment solutions for a broad range of musculoskeletal and regenerative conditions that support the body’s natural ability to heal.

We recently launched our first two products in the regenerative injection and wound care specialties:

A regenerative breakthrough treatment that is a safe, natural alternative for healing soft tissue deficits and injuries. Interfyl® is a decellularized human placental connective tissue matrix (CTM). It contains no residual growth factors, cytokines, cells, cell debris, or DNA. As such it serves as a cell-friendly structure for cell attachment within hours.

Interfyl® helps replace and supplement damaged or inadequate integumental tissue. It supports body's natural ability to heal. It is highly adaptable and suited for a variety of surgical applications. Its flowable form enables it to conform to challenging contours, filling irregular spaces, or soft tissue deficits resulting from trauma or surgery.

It is recommended for conditions such as:
- back and neck pain
- osteoarthritis
- partial rotator cuff tears
- degenerative damage/failing joints
- chronic soft tissue conditions – plantar fasciitis
- tendonitis, ligament disorders (ankles, knees, wrists, shoulders)
Esano™ A is a dehydrated human amniotic membrane allograft protective covering to aid in wound management. It is available in a number of graf sizes.


The Verséa Biologics expert team is looking forward to partnering with Pain Management, Podiatrists, Wound Care, and Orthopedic physicians interested in offering these effective treatment options to their patients.

If you want to receive more information about our regenerative, biologics products, let us know!